Carlson, Andrew P. http://orcid.org/0000-0003-2189-3699
Alchbli, Amal
Hänggi, Daniel
Macdonald, R. Loch
Shuttleworth, C. William
Funding for this research was provided by:
Edge Therapeutics
University of New Mexico department of Neurosurgery
Article History
First Online: 26 February 2020
Conflict of interest
: Carlson—unrestricted educational Grant from Edge Therapeutics. Hänggi—consulting fees for serving on the steering committee for Edge Therapeutics. Macdonald—Grant support from the Brain Aneurysm Foundation and the Canadian Institutes for Health Research; previously Chief Scientific Officer of Edge Therapeutics, Inc., Stock ownership of PDS Biotechnology, Shuttleworth—NINDS.
: All appropriate ethical guidelines were rigorously followed. Informed consent was prospectively used for both studies. Both the monitoring study and the parent RCT were approved by the local IRB (UNM-HRPO-10-159 and UNM-HRPO-16-074).